Reflectance confocal microscopy for margin mapping of melanoma of the lentigo maligna type: A systematic review and meta-analysis
- PMID: 39548723
- DOI: 10.1111/jdv.20383
Reflectance confocal microscopy for margin mapping of melanoma of the lentigo maligna type: A systematic review and meta-analysis
Abstract
Background: Melanoma of the lentigo maligna (LM) type and its invasive counterpart, lentigo maligna melanoma (LMM), occur in chronically sun-damaged skin and tend to have subclinical extension that makes presurgical margin mapping challenging. Reflectance confocal microscopy (RCM) is a non-invasive imaging modality that enables in vivo visualization of the skin at the cellular level, allowing for adequate estimation of LM/LMM margins.
Objectives: We aimed to perform a systematic review and meta-analysis evaluating RCM's performance compared with histopathology in margin mapping of LM/LMM.
Methods: We searched MEDLINE, Embase, Cochrane, and Clinicaltrials.gov for studies published until July 2023, assessing RCM diagnostic accuracy for presurgical LM/LMM margin delineation. Negative predictive value (NPV; number of true negatives confirmed by histopathology out of all negatives found on RCM) was our primary outcome. Secondary outcomes were proportion of agreement between RCM and histopathology, mean number of stages to clear lesion, sensitivity, and specificity.
Results: Of the 955 search results, nine studies (329 participants) were included. Pooled NPV for RCM detection of LM/LMM clear margins was 89.15% (95% CI 80.95-95.46; I2 = 80%). The RCM and histopathology agreement rate was 92.09% (95% CI 84.71-96.07; I2 = 57%). Mean number of stages needed to clear the lesion using RCM was 1.16 (95% CI 1.08-1.23; I2 = 0). Compared with histopathology, RCM sensitivity and specificity were 91.4% (95% CI 82.2-96.1; I2 = 0%) and 95.7% (95% CI 90.7-98; I2 = 68%), respectively.
Conclusions: These results support that RCM has a high concordance rate with the gold standard histopathology for presurgical LM/LMM margin mapping, constituting a valuable tool for its management.
© 2024 European Academy of Dermatology and Venereology.
Similar articles
-
In vivo reflectance confocal microscopy role for early to advanced lentigo maligna melanoma spectrum: A systematic review and pooled analysis.J Eur Acad Dermatol Venereol. 2025 Mar;39(3):555-565. doi: 10.1111/jdv.20389. Epub 2024 Nov 13. J Eur Acad Dermatol Venereol. 2025. PMID: 39535326
-
Lentigo maligna (melanoma): A systematic review and meta-analysis on surgical techniques and presurgical mapping by reflectance confocal microscopy.J Eur Acad Dermatol Venereol. 2023 May;37(5):871-883. doi: 10.1111/jdv.18880. Epub 2023 Jan 31. J Eur Acad Dermatol Venereol. 2023. PMID: 36652277
-
Lentigo maligna melanoma mapping using reflectance confocal microscopy correlates with staged excision: A prospective study.J Am Acad Dermatol. 2023 Feb;88(2):371-379. doi: 10.1016/j.jaad.2019.11.058. Epub 2019 Dec 5. J Am Acad Dermatol. 2023. PMID: 31812621 Free PMC article.
-
Successful implementation of handheld reflectance confocal microscopy as the standard of care in the (surgical) management of lentigo maligna (melanoma).J Eur Acad Dermatol Venereol. 2025 Mar;39(3):604-611. doi: 10.1111/jdv.20210. Epub 2024 Jun 26. J Eur Acad Dermatol Venereol. 2025. PMID: 38923079 Free PMC article.
-
Correlation of Handheld Reflectance Confocal Microscopy With Radial Video Mosaicing for Margin Mapping of Lentigo Maligna and Lentigo Maligna Melanoma.JAMA Dermatol. 2017 Dec 1;153(12):1278-1284. doi: 10.1001/jamadermatol.2017.3114. JAMA Dermatol. 2017. PMID: 29049429 Free PMC article.
Cited by
-
Reflectance Confocal Microscopy Can Help Differentiate Adult Xanthogranulomatous Disease from Xanthelasma-A Case Report.J Clin Med. 2025 Feb 18;14(4):1359. doi: 10.3390/jcm14041359. J Clin Med. 2025. PMID: 40004888 Free PMC article.
-
In Vivo Optical Coherence Tomography for the Detection, Subtyping, and Margin Assessment of Facial Basal Cell Carcinoma: A Comparative Study with Histopathology.J Clin Med. 2025 Feb 1;14(3):949. doi: 10.3390/jcm14030949. J Clin Med. 2025. PMID: 39941619 Free PMC article.
References
REFERENCES
-
- Cohen LM. Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol. 1995;33(6):923–936. quiz 937–40. Erratum in: J Am Acad Dermatol. 1997 Jun;36(6 Pt 1):913.
-
- Swetter SM, Boldrick JC, Jung SY, Egbert BM, Harvell JD. Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990–2000. J Invest Dermatol. 2005;125(4):685–691.
-
- Guitera P, Collgros H, Madronio CM, Goumas C, Mann GJ, Watts CG, et al. The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: population‐based data on diagnosis and management. Australas J Dermatol. 2019;60(2):118–125.
-
- Moreno A, Manrique‐Silva E, Virós A, Requena C, Sanmartín O, Traves V, et al. Histologic features associated with an invasive component in lentigo maligna lesions. JAMA Dermatol. 2019;155(7):782–788.
-
- Menzies SW, Liyanarachchi S, Coates E, Smith A, Cooke‐Yarborough C, Lo S, et al. Estimated risk of progression of lentigo maligna to lentigo maligna melanoma. Melanoma Res. 2020;30(2):193–197.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical